| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.0M | +11.3% | -7.4% |
| Cost of Revenue | $3.0M | +1.1% | -16.4% |
| Gross Profit | $2.1M | +30.3% | +9.4% |
| R&D Expense | $5K | +0.0% | +0.0% |
| SG&A Expense | $669K | -6.6% | -14.0% |
| Operating Income | -$3.4M | -965.8% | -19.6% |
| Net Income | -$3.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $1.1M | +2.5% | -6.1% |
| Inventory | $32K | -22.0% | +68.4% |
| Current Assets | $7.9M | +0.1% | +63.4% |
| Total Assets | $13.3M | -22.7% | -10.6% |
| Current Liabilities | $2.1M | +9.8% | -23.1% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $549K | — | — |
| Capital Expenditures | $7K | — | — |
| Investing Cash Flow | -$2.6M | — | — |
| Financing Cash Flow | $3.2M | — | — |
| Free Cash Flow | $542K | — | — |
| -1053.3% |
| -38.4% |
| EPS (Basic) | -$0.26 | -1200.0% | -13.0% |
| EPS (Diluted) | -$0.26 | -1200.0% | -13.0% |
| $2.2M |
| -20.9% |
| -52.5% |
| Stockholders' Equity | $11.1M | -23.1% | +8.0% |